4115 Stock Overview

Engages in the manufacture and sale of medical devices. More details

4115 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (NT$621M)

Volatile share price over the past 3 months compared to the TW market

My Notes

Capture your thoughts, links and company narrative

Sunder Biomedical Tech. Co., Ltd. Competitors

EPS Bio Technology

TPEX:4183

NT$547.4m

Polylite Taiwan

TPEX:1813

NT$862.7m

Radiant Innovation

TPEX:3373

NT$1.0b

AViTA

TPEX:4735

NT$1.4b

Price History & Performance

Summary of share price highs, lows and changes for Sunder Biomedical Tech
Historical stock prices
Current Share Price	NT$10.35
52 Week High	NT$16.25
52 Week Low	NT$9.90
Beta	0
1 Month Change	0.49%
3 Month Change	-6.76%
1 Year Change	-31.46%
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-44.05%

Recent updates

Shareholder Returns

	4115	TW Medical Equipment	TW Market
7D	0.5%	2.0%	0.4%
1Y	-31.5%	-4.7%	27.0%

Return vs Industry: 4115 underperformed the TW Medical Equipment industry which returned -4.3% over the past year.

Return vs Market: 4115 underperformed the TW Market which returned 27.5% over the past year.

Price Volatility

Is 4115's price volatile compared to industry and market?
4115 volatility
4115 Average Weekly Movement	6.7%
Medical Equipment Industry Average Movement	3.9%
Market Average Movement	4.4%
10% most volatile stocks in TW Market	7.8%
10% least volatile stocks in TW Market	2.1%

Stable Share Price: 4115's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 4115's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of TW stocks.

About the Company

Founded	Employees	CEO	Website
1998	n/a	Yuanqiong Yu	www.sunder.com.tw

Sunder Biomedical Tech. Co., Ltd. engages in the manufacture and sale of medical devices. It offers protective goggles, melt blown nonwoven fabrics and masks, suction irrigation sets, smoke filters, endo bags, blood line sets for hemodialysis, A.V. Fistula needle sets, I.V. administration sets, extension tube, volume control I.V. administration sets, surgical tubing sets, and transducer protector, as well as PVC compounds for medical applications.

Sunder Biomedical Tech. Co., Ltd. Fundamentals Summary

How do Sunder Biomedical Tech's earnings and revenue compare to its market cap?
4115 fundamental statistics
Market cap	NT$621.00m
Earnings (TTM)	NT$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is 4115 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4115 income statement (TTM)
Revenue	NT$0
Cost of Revenue	NT$0
Gross Profit	NT$0
Other Expenses	NT$0
Earnings	NT$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did 4115 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/30 07:22
End of Day Share Price	2024/12/30 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sunder Biomedical Tech. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

Sunder Biomedical Tech TPEX:4115 Stock Report